...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Joe Daniels

Joe Daniels

Verified

Mr Joe Daniels GMC: 4349732 Consultant Gynaecologist (since 2003) – NHS & Private Sector Current roles: Airedale NHS Foundation Trust, Keighley Mid-Yorkshire NHS at Pinderfields Hospital, Wakefield Harley Street, London Clinical interests: General Gynaecology, Urogynaecology, Pelvic Floor Dysfunction, Urinary & Bowel Dysfunction, Sexual Dysfunction, Vaginal Reconstruction, Cosmetic Gynaecology. Background: Trained in Cambridge & Imperial College London, focusing on pelvic floor disorders and MRI research. Extensive private sector experience (2011–2017) in pelvic floor and aesthetic gynaecology. Returned to NHS in 2017 while maintaining private practice. Memberships: British Medical Association Royal College of Obstetricians & Gynaecologists Royal Society of Urogynaecologists

MBBS M.Sc & DIC MRCPI FRCOG
Was this answer helpful?
Authored and medically reviewed by Dr Farzana Khan on 3 July 2026
Rate Joe's explanation
0.0 (5)
womens health clinic faq

start with the basics use products for the right job escalate if symptoms persist

Women’s Health Clinic FAQ

What is the difference between CO2 laser (NuV, Monalisa Touch) and erbium laser for vaginal treatment?

What is the difference between CO2 laser (NuV, Monalisa Touch) and erbium laser for vaginal treatment? CO2 lasers (like NuV and MonaLisa Touch) and erbium lasers both treat vaginal atrophy and dryness, but they differ in the depth and type of tissue interaction. CO2 lasers.

Direct answer

What is the difference between CO2 laser (NuV, Monalisa Touch) and erbium laser for vaginal treatment? CO2 lasers (like NuV and MonaLisa Touch) and erbium lasers both treat vaginal atrophy and dryness, but they differ in the depth and type of tissue interaction. CO2 lasers penetrate deeper, while erbium lasers are more superficial and precise, with less heat spread.

If the symptom pattern is getting harder to explain, you can book a consultation or ask WHC about the next step once you have a clearer record of symptoms, triggers and what you have already tried.

Educational only. Clinical suitability must be confirmed following an appropriate consultation and assessment by a qualified healthcare professional. Results vary. Not a cure.

At a glance

What is the difference between CO2 laser (NuV, Monalisa Touch) and erbium laser for vaginal treatment? CO2 lasers (like NuV and MonaLisa Touch) and erbium lasers both treat vaginal atrophy and dryness, but they differ in the depth and type.

Diagnostic Differentiators

Key physical and clinical parameters

First-line role

simple, regular, product-appropriate self-care is usually first-line

What it helps with

hydration between applications and glide at the time of friction are different jobs

What it does not replace

persistent symptoms can still need vaginal oestrogen, vaginal DHEA or broader review

Best next step

keep the plan gentle, consistent and easy to judge

Critical Progressive Risk

Educational only. Dryness, soreness and intimacy symptoms can overlap with infection, vulval skin disease, medication effects, pelvic-floor issues or deeper pelvic pain, so persistent symptoms deserve review rather than guesswork.

hydration is not the same as glide gentle products matter persisting symptoms deserve options
Detailed answer

How non-hormonal support fits into GSM care

The first-line practical steps are usually simple, but they work best when they are used for the right reason and at the right time.

Key Overlapping Symptom Triggers

Moisturisers, lubricants and gentle vulval care can reduce friction and irritation, but they do not remove the need to reassess if symptoms keep intruding on daily life.

symptom pattern matters do not normalise ongoing discomfort

What this tool is for

CO2 lasers (such as MonaLisa Touch and NuV) and erbium lasers are both fractional laser technologies used for vaginal rejuvenation, but they work differently at a tissue level. CO2 lasers deliver energy that penetrates deeper into the vaginal mucosa, causing controlled thermal.

How to use it well

This can be effective for severe atrophic changes but can cause more heat diffusion and downtime. Erbium:YAG lasers, in contrast, have a higher water absorption rate, making their energy more superficial, precise, and less likely to cause thermal damage to deeper tissues.

What still needs review

This results in a gentler treatment with less downtime and lower risk of scarring. Both approaches can improve symptoms of genitourinary syndrome of menopause (GSM), such as dryness and irritation, but their safety and efficacy profiles differ.

When to move beyond self-care

Current evidence is evolving, and while some women report significant symptom relief, large-scale, long-term studies are still limited. Always seek a consultation with a medical specialist.

Why simple care still needs structure

See further info at RCOG and NHS . Clinical Context Vaginal laser treatments are generally offered to postmenopausal women or those experiencing symptoms such as dryness, pain, or laxity that have not improved with other therapies.

A full clinical assessment is essential to determine suitability, and patients should discuss expectations, risks, and alternatives. Treatment is usually carried out by trained gynaecologists or women's health specialists.

Patient safety

Why product choice still needs clinical common sense

Over-the-counter options can help many women, but ongoing bleeding, discharge, pain or persistent symptoms should still trigger review.

Do not normalise progression

If the pattern is becoming more intrusive, more painful or less recognisable, it deserves a proper explanation rather than repeated guesswork.

Look for overlap

Menopause-related dryness may coexist with irritation, pelvic-floor tension, infection or another diagnosis that changes the plan.

Use the least risky first step

Gentle, evidence-based first-line care is usually sensible, but it should not delay escalation when symptoms persist or worsen.

Keep review thresholds low

Seek review if symptoms keep recurring, start affecting daily life or no longer respond to the same simple measures.

Why the symptom pattern matters

Patient experiences show improvement in symptoms, but it is important to note that not all women respond in the same way. Evidence-Based Approaches According to NICE and RCOG guidance, more research is needed on the long-term safety and efficacy of vaginal laser treatments.

Current evidence suggests some benefit in symptom management, but these devices are not yet standard NHS treatments for GSM.

Considerations

How to make first-line care more useful

The most reliable home steps are usually consistent, gentle and easy to explain rather than experimental, heavily fragranced or stacked without purpose.

Best baseline check

Ask whether the symptom pattern, timing, triggers and wider context all point in the same direction before assuming the first explanation is the right one.

pattern first red flags still matter

Clarify the main driver

Work out whether the main problem is dryness, fragility, irritation, pain or a mix of several layers.

Do not miss another diagnosis

Bleeding, strong odour, discharge, fever, a new lesion or severe pain should trigger broader review rather than a narrow self-care answer.

Use first-line care consistently

If you are using self-care, make sure the products, timing and purpose are clear enough to judge honestly.

Know when to escalate

Escalation is appropriate when symptoms persist, worsen, recur or start affecting intimacy, confidence, sleep or daily function.

What a useful review usually adds

A good review often adds more than a prescription. It clarifies the diagnosis, the red flags, the overlap issues and the most logical next step.

It also reduces the chance of spending months trying the wrong products, blaming yourself, or missing a pattern that should have prompted earlier escalation.

Common concerns and myths

Myths about moisturisers, lubricants and self-care

Simple tools can help, but they are not interchangeable and they are not the whole answer for everyone.

Myth: Moisturiser and lubricant do the same job

False. One supports background hydration and the other reduces friction in the moment.

Myth: More products always mean better results

False. The best early plan is usually consistent, simple and easy to judge.

Myth: If self-care helps a bit, review is unnecessary

False. Partial improvement can still mean a stronger next step is needed.

Why consistency matters

Simple measures work best when they are used regularly enough to judge honestly rather than changed every few days.

Best next step

Escalate if bleeding, discharge, urinary symptoms or daily-life disruption continue despite sensible first-line care.

Eligibility

A practical checklist for deciding what to do next

These points help decide whether home measures still make sense or whether the picture now needs a proper review.

Pattern still fits

The symptoms are mild to moderate, recognisable and not rapidly changing.

No obvious red flags

There is no postmenopausal bleeding, severe pain, foul discharge, fever or new visible lesion.

Daily life still manageable

Comfort, intimacy and confidence are not being steadily eroded while you wait and watch.

Clear follow-up point

You know what would make you stop guessing and seek review instead.

Reassuring Signs Matrix (Green Flags)

Reasonable first steps at home usually include the following evidence-aware checks.

Keeping a simple record of timing, triggers and what the symptoms actually feel like. Avoiding obvious irritants and keeping the product routine simple enough to judge. Escalating sooner if symptoms remain intrusive despite sensible first-line care.

Indicators to Pause and Re-Evaluate (Red Flags)

Seek a clinical review sooner if the pattern is worsening or no longer looks straightforward.

Bleeding after sex, bleeding after menopause or bleeding that keeps recurring. A new lump, ulcer, severe pain, foul discharge or symptoms suggesting infection. Persistent symptoms, repeated flares or daily-life disruption despite sensible self-care.
When to escalate

Signs Demanding Immediate Clinical Evaluation

These symptoms are common, but they should not be brushed off if the pattern changes, persists or starts affecting pain, bleeding, bladder symptoms or quality of life. Access NHS 111 Support

Bleeding needs checking

Postmenopausal bleeding or repeated bleeding after sex should be assessed rather than normalised as simple dryness.

Pain may need a different explanation

Pain can also reflect infection, pelvic-floor spasm, vulval skin disease or another diagnosis that needs a different plan.

Persistent symptoms deserve options

If symptoms are ongoing, ask about evidence-based treatment rather than cycling through unsuitable over-the-counter products.

Daily-life disruption matters

If the symptom pattern is starting to affect intimacy, confidence, exercise, sleep or bladder comfort, it deserves a more structured review.

This safety and escalation advice is purely educational and does not replace emergency medical care. If you are experiencing severe, worsening pain, heavy active bleeding, signs of systemic infection, acute urinary retention, or sudden incontinence, please contact NHS 111, your local GP, or an urgent care centre immediately.

Deep Clinical Context & Common Patient Inquiries

Why simple products can still work well

CO2 lasers (such as MonaLisa Touch and NuV) and erbium lasers are both fractional laser technologies used for vaginal rejuvenation, but they work differently at a tissue level.CO2 lasers deliver energy that penetrates deeper into the vaginal mucosa, causing controlled thermal damage, which stimulates collagen production and tissue remodelling.

What should make you escalate

This can be effective for severe atrophic changes but can cause more heat diffusion and downtime.
  • Use moisturisers for background hydration and lubricants for friction at the time of sex or examination.
  • Re-apply lubrication when needed instead of pushing through pain and hoping it will settle.
  • Escalate if sensible first-line care is not changing day-to-day comfort.
Regulatory resources

Authoritative UK Clinical Resources

Access peer-reviewed guidance from national healthcare bodies to support your understanding of pelvic health conditions.

Recommendations | Urinary incontinence and pelvic organ prolapse in women: management | NICE

NICE sets the UK assessment and conservative-management baseline for urinary incontinence and pelvic organ prolapse, including pelvic floor assessment and specialist physiotherapy input.Read NICE guidance

Urinary incontinence - Non-surgical treatment - NHS

NHS explains that conservative urinary-incontinence care starts with lifestyle change and pelvic floor muscle training before procedures are considered.Read NHS guidance

Pelvic organ prolapse - NHS

NHS outlines prolapse symptoms, examination and the role of physiotherapy, pelvic floor exercises and vaginal hormone treatment where relevant.Read NHS guidance

Next step

Schedule a Confidential Specialist Evaluation

If you are trying sensible non-hormonal options but still not getting reliable comfort, WHC can help compare whether you need different self-care, local oestrogen or a wider menopause plan.

Clinical reference materials used for this FAQ

Educational only. Individual treatment suitability can only be determined by a qualified professional after a thorough consultation and assessment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.